Glaxo Smith Kline has sued Abbott Laboratories for increasing its AIDS drug Norvir, five-fold. Norvir, approved by the FDA in 1996, is known as a protease inhibitor. Abbott is also being sued by 2 AIDS patients as well as the SEIU Health and Welfare Fund. This suit has been classified as a class action. According to Glaxo, the quintuple increase in drug price undercut Glaxo’s Lexiva, another AIDS drug.
For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.
Admitted to both the California State Bar and the Florida State Bar, Joseph Saunders has also practiced in the United States District Court and the United States Court of Appeals. His philosophy is to provide aggressive, quality representation and seek fair compensation for individuals and their families who have suffered injury or death at the hands of insurance companies, large corporations, medical providers or governmental entities.